The Yale Center for the Science of Cannabis and Cannabinoids, YC-SCAN², recently announced that it has awarded more than $600,000 in grants to 14 researchers from the Yale School of Medicine for innovative projects on the impact of cannabis and cannabinoids on neurodevelopment and mental health. These grants reflect YC-SCAN²'s ongoing commitment to advancing research in this rapidly evolving field.
Established in 2023, YC-SCAN² aims to be a leading hub for cannabis and cannabinoid science, conducting cutting-edge research while disseminating key findings to healthcare professionals and the public. Under the direction of Deepak Cyril D'Souza, MD, the center is focused on studying how cannabis affects the brain and overall health, particularly as legal markets continue to grow across the U.S.
